Moderna's mRNA flu shot earns FDA approval after rollercoaster review
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
Tech news from the best sources
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.